It is not intended for human consumption, medical, veterinary, or di
The American Academy of Pediatrics 2019 Clinical Practice Guideline does not recommend one stimulant over another as first-line therapy [5]
In human growth-hormone-deficiency trials using recombinant native IGF-1 (mecasermin, brand name Increlex), the approved dose range is 0.04-0.12 mg/kg twice daily by subcutaneous injection, titrated to IGF-1 levels in the age- and sex-normalised reference range [15]
Multiple other causes should be considered including peripheral vascular disease, neuropathy, medication effects from other drugs (particularly diuretics, beta-agonists, and statins), hypothyroidism, pregnancy, and musculoskeletal conditions
clowes: Early Mad magazine and crazy horror comics and various science fiction digests, which at the time I couldn't actually read